The Puerto Rico Industrial Development Company (PRIDCo) and Actavis announced that the company will develop a solid dosage manufacturing and packing facility at its Manati site and expand its current hormone production in Fajardo.
Actavis is investing $48 million and has committed to create up to 300 new jobs over a 36-month period; it has already has created 100 jobs. The investment will allow the company to bring new lines of generic, brand, and biosimilar products. When the expansion is completed, Actavis will have 700 employees in Puerto Rico.
All plans are expected to be complete by 2016.